Oxidative stress induced by P2X7 receptor stimulation in murine macrophages is mediated by c-Src/Pyk2 and ERK1/2
Article
-
- Overview
-
- Research
-
- Identity
-
- Additional Document Info
-
- View All
-
Overview
abstract
-
Background Activation of ATP-gated P2X7 receptors (P2X7R) in macrophages leads to production of reactive oxygen species (ROS) by a mechanism that is partially characterized. Here we used J774 cells to identify the signaling cascade that couples ROS production to receptor stimulation. Methods J774 cells and mP2X7-transfected HEK293 cells were stimulated with Bz-ATP in the presence and absence of extracellular calcium. Protein inhibitors were used to evaluate the physiological role of various kinases in ROS production. In addition, phospho-antibodies against ERK1/2 and Pyk2 were used to determine activation of these two kinases. Results ROS generation in either J774 or HEK293 cells (expressing P2X7, NOX2, Rac1, p47phox and p67phox) was strictly dependent on calcium entry via P2X7R. Stimulation of P2X7R activated Pyk2 but not calmodulin. Inhibitors of MEK1/2 and c-Src abolished ERK1/2 activation and ROS production but inhibitors of PI3K and p38 MAPK had no effect on ROS generation. PKC inhibitors abolished ERK1/2 activation but barely reduced the amount of ROS produced by Bz-ATP. In agreement, the amount of ROS produced by PMA was about half of that produced by Bz-ATP. Conclusions Purinergic stimulation resulted in calcium entry via P2X7R and subsequent activation of the PKC/c-Src/Pyk2/ERK1/2 pathway to produce ROS. This signaling mechanism did not require PI3K, p38 MAPK or calmodulin. General significance ROS is generated in order to kill invading pathogens, thus elucidating the mechanism of ROS production in macrophages and other immune cells allow us to understand how our body copes with microbial infections. © 2013 Elsevier B.V.
publication date
funding provided via
published in
Research
keywords
-
Calcium; Macrophage; Mitogen-activated protein kinase; Oxidative stress; Purinergic receptor adenosine triphosphate; calcium; calmodulin; enzyme antibody; focal adhesion kinase 2; focal adhesion kinase 2 antibody; mitogen activated protein kinase 1; mitogen activated protein kinase 1 antibody; mitogen activated protein kinase 3; mitogen activated protein kinase 3 antibody; mitogen activated protein kinase p38; phosphatidylinositol 3 kinase; protein inhibitor; protein kinase p60; protein p47; protein p67; purinergic P2X7 receptor; Rac1 protein; reactive oxygen metabolite; reduced nicotinamide adenine dinucleotide phosphate oxidase 2; unclassified drug; animal cell; article; calcium cell level; calcium transport; cell stimulation; controlled study; enzyme activation; enzyme activity; enzyme assay; enzyme inactivation; intracellular signaling; macrophage; mouse; nonhuman; oxidative stress; priority journal; protein expression; protein phosphorylation; 2′,3′-O-(4-benzoyl-benzoyl) ATP; 2′,7′-dichlorodihydrofluorescein diacetate; 2′,7′-dichlorofluorescein; 2-(1-(3 dimethylaminopropyl)-5-methoxyindol-3-yl)-3-(1h-indol-3-yl)maleimide; 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one; 4-[5-(4-fluorophenyl)-2-[4-(methylsulfonyl)phenyl]-1H-imidazol-4-yl]pyridine; 4-amino-5-(4-chlorophenyl)-7-(dimethylethyl) pyrazolo[3,4-d]pyrimidine; 8-amino-5-chloro-7-phenylpyrido [3,4-d]pyridazine-1,4(2H,3H) dione; Bz-ATP; c-Jun N-terminal kinase; Calcium; DCF; DCFH(2)DA; dimethlysulfoxide; diphenyleneiodonium; DMSO; DPI; EGFR; Epidermal Growth Factor Receptor; ERK1/2; extracellular regulated kinases 1 and 2; Fura-2 AM; Fura-2-acetoxymethylester; Gö6983; Hanks's balanced salt solution; HBSS; IL-1β; interleukin-1β; JNK; L-012; lipopolysaccharide; LPS; Macrophage; MAPKs; Mitogen-activated protein kinase; mitogen-activated protein kinases; N-Methyl-N-[2-[[[2-[(2,3-dihydro-2- oxo-1H-indol-5-yl)amino]-5-(trifluoromethyl)-4-pyrimidinyl]amino]methyl]phenyl]methanesulfonamide; Oxidative stress; P2X7 receptor channels; P2X7R; PD98059; PF431396; phorbol myristate acetate; phosphatidylinositol 3 kinase; phospholipase D; PI3K; PLD; PMA; PP2; Purinergic receptor; reactive oxygen species; ROS; saline solution; SB203580; SB239063; SS; TNFα; trans-4-[4-(4-fluorophenyl)-5-(2-methoxy-4-pyrimidinyl)-1H-imidazol-1-yl]cyclohexanol; tumor necrosis factor α; WB; Western blot; Animals; Calcium; Cell Line; Focal Adhesion Kinase 2; Humans; Ion Transport; Macrophages; MAP Kinase Signaling System; Mice; Oxidative Stress; Proto-Oncogene Proteins pp60(c-src); Receptors, Purinergic P2X7; Murinae
Identity
Digital Object Identifier (DOI)
PubMed ID
Additional Document Info
start page
end page
volume
issue